Retatrutide is a new medication in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in investigations. By stimulating these receptors, Retatrutide reduces hunger pangs, {promotesglucose regulation, and ultimately lead